Marshall Wace’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Sell
807,796
-5,118,949
-86% -$4.72M ﹤0.01% 2585
2025
Q4
$13M Buy
5,926,745
+4,156,969
+235% +$6.69M 0.01% 775
2025
Q3
$2.81M Buy
+1,769,776
New +$2.3M ﹤0.01% 1451

Other funds holding GUTS

Marshall Wace's GUTS Position: Q1 2026 in Review

Marshall Wace reduced its Fractyl Health (GUTS) stake by 86% in Q1 2026, selling an estimated $4.72M and leaving 807,796 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Marshall Wace first reported a position in GUTS in Q3 2025 and has held it in 3 quarters since. The position peaked at $13M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Marshall Wace held 807,796 shares of Fractyl Health worth $372K as of Q1 2026.
  • Marshall Wace sold 5,118,949 Fractyl Health shares in Q1 2026, an estimated $4.72M.
  • Fractyl Health made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2585 holding.
  • Marshall Wace first reported a position in Fractyl Health in Q3 2025 and has held it in 3 quarters since.
  • Marshall Wace's Fractyl Health position peaked at $13M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.